Cancer models developed with 3D bioprinting technology allow for rapid evaluation of individual drug responses.

Nuclera’s Key Account Manager shares how their eProtein Discovery system is propelling rapid recombinant protein optimization and its utilization in drug discovery.

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Gut alterations in Alzheimer’s disease can be identified using nano- and micro-XPCT, offering a new method for early disease ...

For International Day of Women and Girls in Science, we’ve curated a selection of books, films and online communities for ...

A novel, freely available AI tool has cut the time it takes to determine chromatin structure from days to minutes. The 3D ...

Ice-repelling properties of polar bear fur sebum offer sustainable solutions for preventing ice buildup on infrastructure.

Jewel Plummer Cobb was a cancer researcher who investigated how hormones, ultraviolet light and chemotherapeutic drugs can ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.